Showing results (91-100 of 177) with videos related to

Sort By:
Pageof 18
Human Brain Mapping|August 1, 2012
Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modelingStefan M Gold, Mary-Frances O'Connor, Raja Gill, et al.
Brain : a Journal of Neurology|November 26, 2025
Cognition in multiple sclerosis within the modern diagnostic and treatment eraJames F Sumowski, Sarah Levy, Ilana Katz Sand, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 8, 2019
Psychological resilience is linked to motor strength and gait endurance in early multiple sclerosisSylvia Klineova, Rachel Brandstadter, Michelle T Fabian, et al.
Brain : a Journal of Neurology|August 31, 2010
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosisSergio E Baranzini, Radhika Srinivasan, Pouya Khankhanian, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 30, 2012
A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosisWei Bian, Kristin Harter, Kathryn E Hammond-Rosenbluth, et al.
International Journal of MS Care|April 21, 2015
Patient preferences for attributes of multiple sclerosis disease-modifying therapies: development and results of a ratings-based conjoint analysisLeslie S Wilson, Aimee Loucks, Gregory Gipson, et al.
Annals of Clinical and Translational Neurology|January 8, 2024
The diagnostic value of the central vein sign in radiologically isolated syndromeCassandre Landes-Chateau, Michael Levraut, Darin T Okuda, et al.
Multiple Sclerosis and Related Disorders|February 10, 2016
Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensionsGiancarlo Comi, Mark S Freedman, Ludwig Kappos, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 18, 2015
Early CNS neurodegeneration in radiologically isolated syndromeChristina J Azevedo, Eve Overton, Sankalpa Khadka, et al.
The Lancet. Neurology|January 28, 2014
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trialChristian Confavreux, Paul O'Connor, Giancarlo Comi, et al.
Pageof 18